Albert Nancy M, Hail Melanie D, Li Jianbo, Young James B
Division of Nursing, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Am J Crit Care. 2004 Nov;13(6):469-79.
An accurate and reliable noninvasive method for determining cardiac output/cardiac index would be valuable for patients with acutely decompensated advanced systolic heart failure.
To determine whether a correlation exists for cardiac output and index determined by using bioimpedance and thermodilution in patients with acutely decompensated complex heart failure and if differences between results with the 2 methods could be explained by the patients' advanced condition.
Cardiac output and index were determined by using bioimpedance and thermodilution in 33 patients. Echocardiographic and electrocardiographic data were assessed to determine if differences between results with the 2 methods could be explained by the patients' advanced condition. Concordance correlation coefficients and Bland-Altman agreement between methods were calculated.
Four patients were excluded from analysis because reliable measurements could not be obtained; the remaining 29 patients constituted the study population. Mean cardiac outputs determined by thermodilution and bioimpedance were 5.48 and 5.40 L/min, respectively (rhoc = 0.89, P < .001), and mean cardiac indexes were 2.67 and 2.65 (rhoc = 0.82, P < .001). Mean bias (limits of agreement) between data pairs was 0.08 (-0.18 to 0.35) L/min (P = .52) for cardiac output and 0.03 (-0.097 to 0.16; P = .61) for cardiac index. Six data pairs (21%) had an absolute percent difference greater than 15%. Of these, 50% had a higher thermodilution value.
Determinations of cardiac output and index by both methods were significantly correlated. Mean bias between the 2 methods was small, suggesting clinical utility for bioimpedance in patients with complex decompensated heart failure.
对于急性失代偿性晚期收缩性心力衰竭患者,一种准确可靠的无创心输出量/心指数测定方法将具有重要价值。
确定在急性失代偿性复杂性心力衰竭患者中,使用生物阻抗法和热稀释法测定的心输出量和心指数之间是否存在相关性,以及两种方法结果的差异是否可由患者的晚期病情来解释。
对33例患者使用生物阻抗法和热稀释法测定心输出量和心指数。评估超声心动图和心电图数据,以确定两种方法结果的差异是否可由患者的晚期病情来解释。计算两种方法之间的一致性相关系数和布兰德-奥特曼一致性。
4例患者因无法获得可靠测量值而被排除在分析之外;其余29例患者构成研究人群。热稀释法和生物阻抗法测定的平均心输出量分别为5.48和5.40L/分钟(rhoc = 0.89,P <.001),平均心指数分别为2.67和2.65(rhoc = 0.82,P <.001)。心输出量数据对之间的平均偏差(一致性界限)为0.08(-0.18至0.35)L/分钟(P =.52),心指数为0.03(-0.097至0.16;P =.61)。6对数据(21%)的绝对百分比差异大于±15%。其中,50%的热稀释值较高。
两种方法测定的心输出量和心指数显著相关。两种方法之间的平均偏差较小,表明生物阻抗法在复杂性失代偿性心力衰竭患者中具有临床实用性。